Last Updated: May 14, 2026

VALACYCLOVIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Valacyclovir, and what generic alternatives are available?

Valacyclovir is a drug marketed by Aiping Pharm Inc, Apotex, Aurobindo Pharma, Chartwell Rx, Cipla, Hetero Labs Ltd V, Hikma, Jubilant Generics, Mylan Pharms Inc, Pharmobedient, Rising, Sun Pharm Inds Ltd, Teva Pharms, Watson Labs Inc, Yiling, and Zydus Lifesciences. and is included in sixteen NDAs.

The generic ingredient in VALACYCLOVIR is valacyclovir hydrochloride. There are twenty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Valacyclovir

A generic version of VALACYCLOVIR was approved as valacyclovir hydrochloride by SUN PHARM INDS LTD on January 31st, 2007.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for VALACYCLOVIR?
  • What are the global sales for VALACYCLOVIR?
  • What is Average Wholesale Price for VALACYCLOVIR?
Summary for VALACYCLOVIR
US Patents:0
Applicants:16
NDAs:16
Drug Prices: Drug price information for VALACYCLOVIR
Drug Sales Revenues: Drug sales revenues for VALACYCLOVIR
DailyMed Link:VALACYCLOVIR at DailyMed
Drug patent expirations by year for VALACYCLOVIR
Drug Prices for VALACYCLOVIR

See drug prices for VALACYCLOVIR

Drug Sales Revenue Trends for VALACYCLOVIR

See drug sales revenues for VALACYCLOVIR

US Patents and Regulatory Information for VALACYCLOVIR

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Lifesciences VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 079137-001 Dec 29, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090370-001 Mar 16, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Yiling VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 209553-002 Mar 18, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aiping Pharm Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 077478-002 May 24, 2010 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan Pharms Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 078518-001 May 24, 2010 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Ltd VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 076588-001 Jan 31, 2007 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for VALACYCLOVIR
Can valacyclovir prevent herpes outbreaks?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links